Orthopediatrics KIDS
NASDAQ KIDS
$26.24 -0.26 (-0.98%)
As of: Aug 20, 2026 · 3:59 PM EDT

Orthopediatrics (KIDS) Non-Current Deffered Revenue (2019)

Orthopediatrics (KIDS) posted quarterly Non-Current Deffered Revenue of $12.4 million for Q4 2019.

Orthopediatrics (KIDS) Non-Current Deffered Revenue (2019) Analysis & Trends

Orthopediatrics (KIDS) has reported Non-Current Deffered Revenue for 1 consecutive years, with $12.4 million the latest figure, recorded in Q4 2019.

  • In Q4 2019, Non-Current Deffered Revenue changed N/A year-over-year to $12.4 million; the TTM figure through Dec 2019 stood at $12.4 million (changed N/A YoY), while the FY2019 annual figure was $12.4 million, changed N/A from the prior year.
  • Non-Current Deffered Revenue steadied at $12.4 million in Q4 2019 per KIDS's latest filing.
  • Across five years, Non-Current Deffered Revenue topped out at $12.4 million in Q4 2019 and bottomed at $12.4 million in Q4 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn -
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn -
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn -
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn -
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn -
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 539.34 Mn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn -
10 Orthopediatrics 631.76 Mn 585.88 Mn 52.37 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2019 12.41 Mn